236 related articles for article (PubMed ID: 28513299)
1. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
[TBL] [Abstract][Full Text] [Related]
2. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Lamph WW; Heyman RA; Hayes JS; Thomazy V; Davies PJ
Clin Cancer Res; 1996 Mar; 2(3):511-20. PubMed ID: 9816198
[TBL] [Abstract][Full Text] [Related]
4. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
5. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
6. The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines.
Choi HS; Kim YK; Yun PY
Mol Biol Rep; 2019 Feb; 46(1):617-625. PubMed ID: 30478746
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM‑19.
Li M; Li Z; Li J; Jin L; Jin C; Han C; Ji X; Sun F
Mol Med Rep; 2015 Dec; 12(6):8185-92. PubMed ID: 26458285
[TBL] [Abstract][Full Text] [Related]
11. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide impedes cancer stemness and enhances radio-sensitivity in oral carcinomas via miR-218 activation.
Yang PY; Hsieh PL; Wang TH; Yu CC; Lu MY; Liao YW; Lee TH; Peng CY
Oncotarget; 2017 Jan; 8(3):4196-4207. PubMed ID: 27926533
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines.
Harada K; Ferdous T; Kobayashi H; Ueyama Y
Int J Oncol; 2014 Dec; 45(6):2439-45. PubMed ID: 25230791
[TBL] [Abstract][Full Text] [Related]
14.
Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
[TBL] [Abstract][Full Text] [Related]
15. [Effects of salinomycin on proliferation and apoptosis of oral squamous cell carcinoma].
Su LZ; Chen J; Li X; Ji P
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):902-906. PubMed ID: 33047727
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of chloroquine in promoting sensitivity of chemotherapeutics in oral squamous cell carcinoma CAL-27 cell line to cisplatin].
Quan HY; Quan HY; Zhou LJ; Li AD; Zhang ZB
Shanghai Kou Qiang Yi Xue; 2015 Feb; 24(1):30-6. PubMed ID: 25858366
[TBL] [Abstract][Full Text] [Related]
17. MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.
Liu T; Guan F; Wang Y; Zhang Z; Li Y; Cui Y; Li Z; Liu H; Zhang Y; Wang Y; Ma S
Toxicol Appl Pharmacol; 2020 May; 395():114971. PubMed ID: 32217144
[TBL] [Abstract][Full Text] [Related]
18. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
[TBL] [Abstract][Full Text] [Related]
19. [The inhibitory effect of metformin on oral squamous cell carcinoma].
Wang L; Wang Z; Zhao X; Ji N; Zhou Y; Li J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jun; 50(6):360-5. PubMed ID: 26359040
[TBL] [Abstract][Full Text] [Related]
20. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]